However, a meta-analysis study indicated that AFP with ultrasound detected early-stage HCC with 63% sensitivity (95% CI, 48–75%), while that without ultrasound detected early-stage HCC with 45% sensitivity (95% CI, 30–62%) [84]. The gene discussed is AFP; the disease is hepatocellular carcinoma.